Pharmaceutically acceptable salts and polymorphic forms

C - Chemistry – Metallurgy – 07 – F

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07F 9/58 (2006.01) A61K 31/663 (2006.01) A61P 19/00 (2006.01)

Patent

CA 2649489

The present invention is concerned with new risedronate salts and new polymorphic forms thereof, specifically a pharmaceutically acceptable tetra-(alkali metal) salt of risedronic acid and new polymorphic forms thereof, processes of preparing the same, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.

La présente invention concerne de nouveaux sels risedronates et de nouvelles formes polymorphes de ceux-ci, notamment un sel pharmaceutiquement acceptable de tétra-(métal alcalin) de l'acide risedronique et de nouvelles formes polymorphes de celui-ci, des procédés permettant de les préparer, des compositions pharmaceutiques les contenant, leurs utilisations thérapeutiques et des procédés de traitement les employant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutically acceptable salts and polymorphic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutically acceptable salts and polymorphic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable salts and polymorphic forms will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1679796

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.